Literature DB >> 21097619

The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L,D-transpeptidases.

Marie Lavollay1, Martine Fourgeaud, Jean-Louis Herrmann, Lionel Dubost, Arul Marie, Laurent Gutmann, Michel Arthur, Jean-Luc Mainardi.   

Abstract

Few therapeutic alternatives remain for the treatment of infections due to multiresistant Mycobacterium abscessus. Here we show that the peptidoglycans of the "rough" and "smooth" morphotypes contain predominantly 3→3 cross-links generated by l,d-transpeptidases, indicating that these enzymes are attractive targets for the development of efficient drugs.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21097619      PMCID： PMC3021224          DOI： 10.1128/JB.00606-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  21 in total

Review 1.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

Review 2.  Mycobacterium abscessus: an emerging rapid-growing potential pathogen.

Authors:  Björn Petrini
Journal:  APMIS       Date:  2006-05       Impact factor: 3.205

3.  Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection.

Authors:  T F Byrd; C R Lyons
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype.

Authors:  Susan T Howard; Elizabeth Rhoades; Judith Recht; Xiuhua Pang; Anny Alsup; Roberto Kolter; C Rick Lyons; Thomas F Byrd
Journal:  Microbiology       Date:  2006-06       Impact factor: 2.777

5.  A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathway.

Authors:  Jean-Luc Mainardi; Martine Fourgeaud; Jean-Emmanuel Hugonnet; Lionel Dubost; Jean-Paul Brouard; Jamal Ouazzani; Louis B Rice; Laurent Gutmann; Michel Arthur
Journal:  J Biol Chem       Date:  2005-09-06       Impact factor: 5.157

6.  Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls.

Authors:  M McNeil; M Daffe; P J Brennan
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

7.  The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin.

Authors:  Radhika Gupta; Marie Lavollay; Jean-Luc Mainardi; Michel Arthur; William R Bishai; Gyanu Lamichhane
Journal:  Nat Med       Date:  2010-03-21       Impact factor: 53.440

8.  Synthesis of mosaic peptidoglycan cross-bridges by hybrid peptidoglycan assembly pathways in gram-positive bacteria.

Authors:  Ana Arbeloa; Jean-Emmanuel Hugonnet; Anne-Charlotte Sentilhes; Nathalie Josseaume; Lionnel Dubost; Christelle Monsempes; Didier Blanot; Jean-Paul Brouard; Michel Arthur
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

Review 9.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Mycobacterium abscessus and children with cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Muriel Le Bourgeois; Catherine Pierre-Audigier; Catherine Offredo; Didier Guillemot; Sophie Halley; Chantal Akoua-Koffi; Véronique Vincent; Valérie Sivadon-Tardy; Agnès Ferroni; Patrick Berche; Pierre Scheinmann; Gérard Lenoir; Jean-Louis Gaillard
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883
View more
  50 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates.

Authors:  Elizabeth Story-Roller; Christos Galanis; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Two dd-Carboxypeptidases from Mycobacterium smegmatis Affect Cell Surface Properties through Regulation of Peptidoglycan Cross-Linking and Glycopeptidolipids.

Authors:  Satya Deo Pandey; Shilpa Pal; Ganesh Kumar N; Ankita Bansal; Sathi Mallick; Anindya S Ghosh
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

4.  Genetic characterization of mycobacterial L,D-transpeptidases.

Authors:  Akeisha N Sanders; Lori F Wright; Martin S Pavelka
Journal:  Microbiology (Reading)       Date:  2014-05-21       Impact factor: 2.777

Review 5.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

6.  Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

7.  Diaminopimelic Acid Amidation in Corynebacteriales: NEW INSIGHTS INTO THE ROLE OF LtsA IN PEPTIDOGLYCAN MODIFICATION.

Authors:  Marjorie Levefaudes; Delphine Patin; Célia de Sousa-d'Auria; Mohamed Chami; Didier Blanot; Mireille Hervé; Michel Arthur; Christine Houssin; Dominique Mengin-Lecreulx
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

8.  Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

9.  Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams.

Authors:  Maia K Schoonmaker; William R Bishai; Gyanu Lamichhane
Journal:  J Bacteriol       Date:  2014-01-24       Impact factor: 3.490

10.  Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.

Authors:  Pradeep Kumar; Kriti Arora; John R Lloyd; Ill Y Lee; Vinod Nair; Elizabeth Fischer; Helena I M Boshoff; Clifton E Barry
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.